Peptone

Peptone is a biotechnology company founded in 2018 and based in London, UK, with a significant research and development hub in Bellinzona, Switzerland. The company specializes in AI-driven small-molecule therapeutics that target intrinsically disordered proteins (IDPs), which are linked to various diseases, including cancer and inflammatory conditions. Peptone has established advanced laboratory facilities in Bellinzona, making it a leader in IDP research.

The company employs a multidisciplinary team of experts in fields such as cell biology, medicinal chemistry, and computational biophysics. Peptone's proprietary technology integrates experimental biophysics, supercomputing, and machine learning to model disordered proteins and identify druggable pockets. This innovative approach allows Peptone to develop novel therapeutics aimed at previously undruggable targets. The company is focused on advancing its research and development pipeline to address significant medical challenges.